XML 40 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Summary Of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Schedule of financial assets and liabilities measured on a recurring basis
   2020 
   Level 1   Level 2   Level 3   Fair Value   Carrying
Value
 
                     
Liabilities                         
Contingent Purchase Price Payable (1)  $-   $-   $1,610,813   $1,610,813   $1,610,813 
   2019 
   Level 1   Level 2   Level 3   Fair Value   Carrying
Value
 
                     
Liabilities                         
Contingent Purchase Price Payable (1)  $-   $-   $6,720,000   $6,720,000   $6,720,000 
  (1) The contingent consideration is based off achieving certain revenue milestones in each of the next two years. The Geometric-Brownian motion analysis was used to generate spot prices for use in an option pricing model. For 2019, the hypothetical spot prices were simulated using a Monte Carlo simulation utilizing 2020 and 2021 projected revenue as a base and revenue volatility of 40%. The risk-free rate of return and terms utilized were 1.4 % and 1-2 years, respectively, and expected volatility was 40%. For 2020, the final payout has been determined and is payable in 2021.
Schedule of changes in fair value of the Company’s Level 3 financial instruments
   Amount 
Balance December 31, 2018  $2,365,000 
Contingent consideration liability recorded as the result of the RMDY Health, Inc. acquisition (see note 3)   3,720,000 
Increase in the value of the CareSpeak Communication consideration   635,000 
Balance December 31, 2019   6,720,000 
Increase in fair value of the RMDY Health, Inc. contingent consideration   140,390 
Payment of CareSpeak Communication contingent consideration   (1,389,187)
Payment of RMDY Health, Inc. contingent consideration   (3,860,390)
Balance December 31, 2020  $1,610,813 
Schedule of expected dividends
    2020     2019  
             
Expected dividend yield     0 %     0 %
Risk free interest rate     0.16% - 1.63 %     1.51% - 2.37 %
Expected option term     3.5 years       3.5 years  
Turnover/forfeiture rate     0 %     0 %
Expected volatility     65 % - 71 %     64% - 67 %
Schedule of weighted average shares outstanding and the basic and diluted earnings per common share
    Net Loss     Shares     Per Share
Amount
 
Year ended December 31, 2020                        
Basic EPS   $ (2,207,127 )     14,827,923     $ (0.15 )
                         
Diluted EPS   $ (2,207,127 )     14,827,923     $ (0.15 )
    Net Loss     Shares     Per Share
Amount
 
Year ended December 31, 2019                        
Basic EPS   $ (3,142,576 )     13,387,863     $ (0.23 )
                         
Diluted EPS   $ (3,142,576 )     13,387,863     $ (0.23 )